#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10760	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2080	509.9	0	.	n	.	0	C451T	SNP	451	451	C	678	678	T	604	T,C	417,177	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10760	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2080	509.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	605	C	591	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3547	541.6	0	.	n	.	0	T695C	SNP	695	695	T	1047	1047	C	581	C	567	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3547	541.6	0	.	n	.	0	G888A	SNP	888	888	G	1240	1240	A	618	A,G	347,244	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3547	541.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2323	2323	C	589	C,T,G	573,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3547	541.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2397	2397	A	591	A	583	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3547	541.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2949	2949	C	556	C	542	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3547	541.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1990	1990	A	565	A,G	266,292	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	14	blaTEM	861	208	100.0	blaTEM.l15.c4.ctg.1	208	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1344	folP	855	855	100.0	folP.l15.c4.ctg.1	1581	84.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1079	1081	AGC	142;143;145	A;G;C	137;139;141	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3972	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	116.2	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	126;124;124	T;T;C	125;124;123	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3972	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	116.2	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	129;128;127	G;G;C	126;126;126	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3972	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	116.2	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	129;128;127	G;G;C	126;126;126	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1184	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1499	78.4	1	SNP	p	G45D	0	.	.	133	135	GGC	604	606	GGC	162;160;158	G;G;C	154;153;152	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	668	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	805	80.7	0	.	n	.	0	A197.	DEL	197	197	A	487	487	A	137	A	135	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3480	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2923	117.6	1	SNP	p	D86N	0	.	.	256	258	GAC	527	529	GAC	148;147;148	G;A;C	144;137;145	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3480	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2923	117.6	1	SNP	p	R87W	0	.	.	259	261	CGT	530	532	CGT	149;149;147	C,A;G;T	144,1;142;140	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3480	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2923	117.6	1	SNP	p	S87R	1	.	.	259	261	CGT	530	532	CGT	149;149;147	C,A;G;T	144,1;142;140	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3480	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2923	117.6	1	SNP	p	R87I	0	.	.	259	261	CGT	530	532	CGT	149;149;147	C,A;G;T	144,1;142;140	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3480	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2923	117.6	1	SNP	p	S88P	0	.	.	262	264	TCC	533	535	TCC	146;149;151	T;C;C	140;145;145	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2996	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2634	112.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	151;148;144	G;G;C,T	148;140;138,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1349	1351	GCC	152;152;154	G;C;C	147;147;149	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1352	1354	ATG	156;155;153	A;T;G,T	151;149;147,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1364	1366	ACC	148;145;145	A;C;C	137;139;140	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1364	1366	ACC	148;145;145	A;C;C	137;139;140	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1865	1867	ACC	146;146;143	A;C;C	142;144;141	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1919	1921	GCG	133;132;131	G;C;G	133;131;129	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1919	1921	GCG	133;132;131	G;C;G	133;131;129	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2042	2044	GGT	119;121;121	G;G;T	117;117;117	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2051	2053	AGC	112;110;109	A;G;C	108;108;106	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2874	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2561	111.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2069	2071	CCG	85;85;85	C;C;G	75;76;66	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4042	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3078	130.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1633	1635	CCG	143;144;146	C;C,T,G;G,C	132;138,1,1;135,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1998	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1849	107.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	133	C,A	124,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1902	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1562	120.4	0	.	p	.	0	V37I	NONSYN	109	111	GTA	367	369	ATA	160;159;161	A;T;A	154;152;154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1902	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1562	120.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	907	909	GGT	154;154;153	G;G;T	152;154;150	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1902	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1562	120.4	1	SNP	p	G120K	1	.	.	358	360	AAG	616	618	AAG	142;140;138	A;A;G	137;136;135	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1902	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1562	120.4	1	SNP	p	N121D	0	.	.	361	363	AAC	619	621	AAC	140;141;141	A;A;C,A	138;138;136,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1902	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1562	120.4	1	SNP	p	A121N	1	.	.	361	363	AAC	619	621	AAC	140;141;141	A;A;C,A	138;138;136,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6870	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4727	143.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	786	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1091	71.6	1	SNP	p	V57M	1	.	.	169	171	ATG	531	533	ATG	150;150;149	A;T;G	148;147;147	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
